At least one of us can admit to being wrong.........Also, how's Oncothyreon doing? IMO going nowhere fast. Their PI3K seems like a dud....Stimuvax will be on the dud list soon enough.
Ha! You are not the worst. The BV mod + sidekicks have always liked to show up on other boards when a biotech is down. And ignore - or delete - it when its up. I hope MNTA was not too expensive... when I posted there late last year, I had 3 stocks that were all around $9-$10 - AMRN, ELN + SPPI. All 3 have since galloped past MNTA, as I had expected - and the irony is that all 3 were reviled on BV.
ONTY - I wouldnt draw any conclusions from interim data - even the PI3K data was just interim p1 stuff. As for Stimi, I see the interim as a 'pass' and find it optimitic. We will see.